Lv0
0 积分 2025-10-09 加入
MDM2-PROTAC versus MDM2 Inhibitors: Beyond p53 Reactivation
3小时前
待确认
Discovery of MD-265: A Potent MDM2 Degrader That Achieves Complete Tumor Regression and Improves Long-Term Survival of Mice with Leukemia
3小时前
已完结
Discovery of MD-265: A Potent MDM2 Degrader That Achieves Complete Tumor Regression and Improves Long-Term Survival of Mice with Leukemia
3小时前
已完结
皖公网安备34019202002308
